The Sun Pharmaceuticals Limited is a large cap pharmaceutical company belonging to Nifty 50 group. For this reason, Sun Pharma share price influences the benchmark index.

Live Stock Quote: Unfortunately, we could not get stock quote NSE:SUNPHARMA this time.

Sun Pharma Share Price Graph




Sun Pharma was incorporated in 1983 as a drug manufacturing company with 5 drugs for psychiatric treatment in its kitty. Later drugs for the treatment of cardiac disorder were added in drug portfolio. This division of drugs made Sun Pharma pioneer in this. Sun Pharma introduced many new drugs in the IPM (Indian Pharma Market) in cardiology division. In 1994 Sun Pharma shares were added in NSE and BSE for trading.

Today Sun Pharma is a large cap drug manufacturing company having an international presence in more than 30 countries. Sun Pharma, besides drug manufacturing, has also forayed into API (active pharmaceutical ingredients) business. Some famous brands manufactured from Sun Pharma and the API business has made it a market leader and generated great revenue for the company. It’s branded product portfolio includes drugs in psychiatry, cardiology, gastroenterology, diabetology, neurology, respiratory and drugs used of chronic therapy in these divisions.

Sun Pharma has 19 manufacturing units in India, Bangladesh, US and Hungary. APIs and branded drugs manufactured from these plants are marketed worldwide. The manufacturing units have approval from international authorities like US FDA, UK MHRA.  In addition, Sun Pharma is also a big name in speciality therapy area. It manufactures drugs for following speciality therapies.

  • CNS
  • Diabetes
  • Cardiology
  • Ophthalmology
  • Metabolic Disorders
  • Gastroenterology
  • Allergy
  • Oncology
  • Gynecological
  • Asthma
  • Pain
  • Inflammation

Sun Pharma is a large cap drug manufacturing company in India and has been awarded many times for award of excellence in the pharma sector.

Company Financials – Sun Pharma share price is Rs 569.00 (as on 30.06.17, 11.41 hrs.) in BSE. As per latest data, the standalone basis P/E is 0.00 (consolidated P/E 18.55 and EPS Rs. 29.03) versus average industry PE of 28.03, EPS is Rs -0.15. Market cap is Rs 1,29,203 crores. The face value of a share is Rs 1.

For more information on other companies, kindly visit the stock technicals page.